Edition:
United States

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Capital Market

1.56USD
18 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.56
Open
$1.60
Day's High
$1.60
Day's Low
$1.56
Volume
469
Avg. Vol
31,945
52-wk High
$24.50
52-wk Low
$1.37

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.420
Jun '18 0.00 -7.482
Mar '18 0.00 -83.463
FY 2017 Dec '17 0.00 -3.404
Sep '17 0.00 -6.989
Jun '17 0.00 -4.925
Mar '17 0.00 -4.981
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Quarter Ending Jun-19 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 1 -0.30 -0.30 -0.30 --
Quarter Ending Jun-19 1 -0.31 -0.31 -0.31 --
Year Ending Dec-19 1 -1.09 -1.09 -1.09 -14.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.02 33.71
P/E High - Last 5 Yrs. 26.83 74.33 49.93
P/E Low - Last 5 Yrs. 26.83 20.27 24.27
Beta 3.34 0.93 0.90
Price to Sales (TTM) -- 8.48 6.28
Price to Book (MRQ) 2.80 4.09 5.27
Price to Tangible Book (MRQ) 2.80 5.49 6.79
Price to Cash Flow (TTM) -- 17.97 24.84
% Owned Institutions 18.71 18.32 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.77 1.40
Dividend Yield - 5 Year Avg -- 0.65 1.42
Dividend 5 Year Growth Rate -- 6.36 4.83
Payout Ratio(TTM) -- 22.35 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 13.11 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 6.32 5.87
Sales - 5 Yr. Growth Rate -- 3.01 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -21.24 45.71 47.26
EPS (TTM) vs TTM 1 Yr. Ago -15.83 -- --
EPS - 5 Yr. Growth Rate -- 3.93 10.82
Capital Spending - 5 Yr. Growth Rate -17.44 10.59 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.71 2.26
Current Ratio (MRQ) 5.89 2.22 3.08
LT Debt to Equity (MRQ) 3.32 41.60 11.38
Total Debt to Equity (MRQ) 5.62 52.31 16.13
Interest Coverage (TTM) -- 19.38 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.99 53.78
Gross Margin - 5 Yr. Avg. -- 55.44 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 15.53 12.87
Operating Margin (TTM) -- -1.10 6.20
Operating Margin - 5 Yr. Avg. -- 7.24 8.31
Pre-Tax Margin (TTM) -- -0.34 7.17
Pre-Tax Margin - 5 Yr. Avg. -- 6.40 8.61
Net Profit Margin (TTM) -- -2.27 3.30
Net Profit Margin - 5 Yr. Avg. -- 4.38 4.88
Effective Tax Rate (TTM) -- 15.97 22.88
Effective Tax Rate - 5 Yr. Avg. -- 20.76 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 16,209,664 844,239,566
Net Income/Employee (TTM) -658,405 1,433,978 100,064,145
Receivable Turnover (TTM) -- 5.51 5.72
Inventory Turnover (TTM) -- 4.49 3.48
Asset Turnover (TTM) 0.00 0.79 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.62 1.28 11.08
Return on Assets - 5 Yr. Avg. -118.83 4.50 12.21
Return on Investment (TTM) -83.17 9.63 14.48
Return on Investment - 5 Yr. Avg. -273.41 6.13 15.88
Return on Equity (TTM) -86.11 15.55 15.99
Return on Equity - 5 Yr. Avg. -337.83 9.62 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 40.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for InVivo Therapeutics Holdings Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.79%
# of Holders: 32
Total Shares Held: 1,004,392
3 Mo. Net Change: 465,119
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 1
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.